Wouter van Elmpt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wouter van Elmpt has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
P. Lambin
Department of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Centre (MUMC), Maastricht, The Netherlands
3 shared publications- Ala Yaromina
The M-Lab, Department of Precision Medicine, GROW—School for Oncology and Reproduction, Maastricht University, 6229 ER Maastricht, The Netherlands
2 shared publications - Andre Dekker
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands
2 shared publications - Colien Hazelaar
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+ , Maastricht
2 shared publications - Dirk De Ruysscher
Maastro Clinic Maastricht, Limburg Netherlands
2 shared publications - Jakub Cvek
Department of Oncology, University Hospital and Faculty of Medicine, Ostrava, Czech Republic
2 shared publications
Latest Publications
- Open Access
- 12 March 2026
- Published by Elsevier in SSRN Electronic Journal
Expert trained AI-models as a paradigm shift for disseminating radiotherapy contouring guidelines: The EPTN consensus atlas for CT- and MR-based neuro-oncology contouring
We present an expert-trained deep learning model for automated delineation of 25 organs-at-risk defined in the EPTN atlas for neuro-oncological radiotherapy. Multiple input configurations were evaluated. The dual-input channel model combining contrast-enhanced T1-weighted MRI and CT achieved the best overall results (median surface Dice Similarity Coefficient = 0.84). It demonstrated robust performance across a wide range of organs-at-risk, supporting its use as a segmentation-support tool under human supervision and for fully automated retrospective dose–response analyses. We release the model publicly to the international community, while explicitly acknowledging that clinical use remains the responsibility of each institution within its regulatory context.
- 12 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessExpert trained AI-models as a paradigm shift for disseminating radiotherapy contouring guidelines: The EPTN consensus atlas for CT- and MR-based neuro-oncology contouring
We present an expert-trained deep learning model for automated delineation of 25 organs-at-risk defined in the EPTN atlas for neuro-oncological radiotherapy. Multiple input configurations were evaluated. The dual-input channel model combining contrast-enhanced T1-weighted MRI and CT achieved the best overall results (median surface Dice Similarity Coefficient = 0.84). It demonstrated robust performance across a wide range of organs-at-risk, supporting its use as a segmentation-support tool under human supervision and for fully automated retrospective dose–response analyses. We release the model publicly to the international community, while explicitly acknowledging that clinical use remains the responsibility of each institution within its regulatory context.
- Open Access
- 1 December 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 8 (8) , e2400101
Implementation Strategy for Artificial Intelligence in Radiotherapy: Can Implementation Science Help?
PURPOSE: Artificial intelligence (AI) applications in radiotherapy (RT) are expected to save time and improve quality, but implementation remains limited. Therefore, we used implementation science to develop a format for designing an implementation strategy for AI. This study aimed to (1) apply this format to develop an AI implementation strategy for our center; (2) identify insights gained to enhance AI implementation using this format; and (3) assess the feasibility and acceptability of this format to design a center-specific implementation strategy for departments aiming to implement AI. METHODS: We created an AI-implementation strategy for our own center using implementation science methods. This included a stakeholder analysis, literature review, and interviews to identify facilitators and barriers, and designed strategies to overcome the barriers. These methods were subsequently used in a workshop with teams from seven Dutch RT centers to develop their own AI-implementation plans. The applicability, appropriateness, and feasibility were evaluated by the workshop participants, and relevant insights for AI implementation were summarized. RESULTS: The stakeholder analysis identified internal (physicians, physicists, RT technicians, information technology, and education) and external (patients and representatives) stakeholders. Barriers and facilitators included concerns about opacity, privacy, data quality, legal aspects, knowledge, trust, stakeholder involvement, ethics, and multidisciplinary collaboration, all integrated into our implementation strategy. The workshop evaluation showed high acceptability (18 participants [90%]), appropriateness (17 participants [85%]), and feasibility (15 participants [75%]) of the implementation strategy. Sixteen participants fully agreed with the format. CONCLUSION: Our study highlights the need for a collaborative approach to implement AI in RT. We designed a strategy to overcome organizational challenges, improve AI integration, and enhance patient care. Workshop feedback indicates the proposed methods are useful for multiple RT centers. Insights gained by applying the methods highlight the importance of multidisciplinary collaboration in the development and implementation of AI.
- 1 December 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 8 (8) , e2400101
Open AccessImplementation Strategy for Artificial Intelligence in Radiotherapy: Can Implementation Science Help?
PURPOSE: Artificial intelligence (AI) applications in radiotherapy (RT) are expected to save time and improve quality, but implementation remains limited. Therefore, we used implementation science to develop a format for designing an implementation strategy for AI. This study aimed to (1) apply this format to develop an AI implementation strategy for our center; (2) identify insights gained to enhance AI implementation using this format; and (3) assess the feasibility and acceptability of this format to design a center-specific implementation strategy for departments aiming to implement AI. METHODS: We created an AI-implementation strategy for our own center using implementation science methods. This included a stakeholder analysis, literature review, and interviews to identify facilitators and barriers, and designed strategies to overcome the barriers. These methods were subsequently used in a workshop with teams from seven Dutch RT centers to develop their own AI-implementation plans. The applicability, appropriateness, and feasibility were evaluated by the workshop participants, and relevant insights for AI implementation were summarized. RESULTS: The stakeholder analysis identified internal (physicians, physicists, RT technicians, information technology, and education) and external (patients and representatives) stakeholders. Barriers and facilitators included concerns about opacity, privacy, data quality, legal aspects, knowledge, trust, stakeholder involvement, ethics, and multidisciplinary collaboration, all integrated into our implementation strategy. The workshop evaluation showed high acceptability (18 participants [90%]), appropriateness (17 participants [85%]), and feasibility (15 participants [75%]) of the implementation strategy. Sixteen participants fully agreed with the format. CONCLUSION: Our study highlights the need for a collaborative approach to implement AI in RT. We designed a strategy to overcome organizational challenges, improve AI integration, and enhance patient care. Workshop feedback indicates the proposed methods are useful for multiple RT centers. Insights gained by applying the methods highlight the importance of multidisciplinary collaboration in the development and implementation of AI.
- Open Access
- 30 September 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (10) , ytae541
3D-targeted, electrocardiographic imaging-aided stereotactic radioablation for ventricular tachycardia storm: a case report
Stereotactic arrhythmia radioablation (STAR) is a promising non-invasive therapy for patients with ventricular tachycardia (VT). Accurate identification of the arrhythmogenic volume, or clinical target volume (CTV), on the radiotherapy (RT) 4D planning computed tomography (CT) scan is key for STAR efficacy and safety. This case report illustrates our workflow of electro-structural image integration for CTV delineation. A 72-year-old man with ischaemic cardiomyopathy and VT storm, despite two (endocardial and epicardial) catheter-based ablations, was consented for STAR. A 3D electro-structural arrhythmia model was generated from co-registered electroanatomical voltage and activation maps, electrocardiographic (ECG) imaging, and the cardiac CT angiography scan (in ADAS 3D), pinpointing the VT isthmus and inferoapical VT exit. At this location, an area with short recovery times was found with ECG imaging. A multidisciplinary team delineated the CTV on the transmural ventricular myocardium, which was fused with the 4D planning CT scan using a digital images and communication in medicine (DICOM) radiotherapy file. The CTV was 63% smaller compared with using the conventional American Heart Association 17-segment approach (11 vs. 24 cm3). A single fraction of 25 Gy was delivered to the internal target volume. After an 8-week blanking period, no VT recurrences or radiation-related side-effects were noted. Eight months later, the patient died from end-stage heart failure. We report a novel workflow for 3D-targeted and ECG imaging-aided CTV delineation for STAR, resulting in a smaller irradiated volume compared with segmental approaches. Acute and intermediate outcome and safety were favourable. Non-invasive ECG imaging at baseline and during induced VT holds promise for STAR guidance.
- 30 September 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 8 (10) , ytae541
Open Access3D-targeted, electrocardiographic imaging-aided stereotactic radioablation for ventricular tachycardia storm: a case report
Stereotactic arrhythmia radioablation (STAR) is a promising non-invasive therapy for patients with ventricular tachycardia (VT). Accurate identification of the arrhythmogenic volume, or clinical target volume (CTV), on the radiotherapy (RT) 4D planning computed tomography (CT) scan is key for STAR efficacy and safety. This case report illustrates our workflow of electro-structural image integration for CTV delineation. A 72-year-old man with ischaemic cardiomyopathy and VT storm, despite two (endocardial and epicardial) catheter-based ablations, was consented for STAR. A 3D electro-structural arrhythmia model was generated from co-registered electroanatomical voltage and activation maps, electrocardiographic (ECG) imaging, and the cardiac CT angiography scan (in ADAS 3D), pinpointing the VT isthmus and inferoapical VT exit. At this location, an area with short recovery times was found with ECG imaging. A multidisciplinary team delineated the CTV on the transmural ventricular myocardium, which was fused with the 4D planning CT scan using a digital images and communication in medicine (DICOM) radiotherapy file. The CTV was 63% smaller compared with using the conventional American Heart Association 17-segment approach (11 vs. 24 cm3). A single fraction of 25 Gy was delivered to the internal target volume. After an 8-week blanking period, no VT recurrences or radiation-related side-effects were noted. Eight months later, the patient died from end-stage heart failure. We report a novel workflow for 3D-targeted and ECG imaging-aided CTV delineation for STAR, resulting in a smaller irradiated volume compared with segmental approaches. Acute and intermediate outcome and safety were favourable. Non-invasive ECG imaging at baseline and during induced VT holds promise for STAR guidance.
- Open Access
- 1 August 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400173
Potential of E-Learning Interventions and Artificial Intelligence–Assisted Contouring Skills in Radiotherapy: The ELAISA Study
PURPOSE: Most research on artificial intelligence–based auto-contouring as template (AI-assisted contouring) for organs-at-risk (OARs) stem from high-income countries. The effect and safety are, however, likely to depend on local factors. This study aimed to investigate the effects of AI-assisted contouring and teaching on contouring time and contour quality among radiation oncologists (ROs) working in low- and middle-income countries (LMICs). MATERIALS AND METHODS: Ninety-seven ROs were randomly assigned to either manual or AI-assisted contouring of eight OARs for two head-and-neck cancer cases with an in-between teaching session on contouring guidelines. Thereby, the effect of teaching (yes/no) and AI-assisted contouring (yes/no) was quantified. Second, ROs completed short-term and long-term follow-up cases all using AI assistance. Contour quality was quantified with Dice Similarity Coefficient (DSC) between ROs' contours and expert consensus contours. Groups were compared using absolute differences in medians with 95% CIs. RESULTS: AI-assisted contouring without previous teaching increased absolute DSC for optic nerve (by 0.05 [0.01; 0.10]), oral cavity (0.10 [0.06; 0.13]), parotid (0.07 [0.05; 0.12]), spinal cord (0.04 [0.01; 0.06]), and mandible (0.02 [0.01; 0.03]). Contouring time decreased for brain stem (–1.41 [–2.44; –0.25]), mandible (–6.60 [–8.09; –3.35]), optic nerve (–0.19 [–0.47; –0.02]), parotid (–1.80 [–2.66; –0.32]), and thyroid (–1.03 [–2.18; –0.05]). Without AI-assisted contouring, teaching increased DSC for oral cavity (0.05 [0.01; 0.09]) and thyroid (0.04 [0.02; 0.07]), and contouring time increased for mandible (2.36 [–0.51; 5.14]), oral cavity (1.42 [–0.08; 4.14]), and thyroid (1.60 [–0.04; 2.22]). CONCLUSION: The study suggested that AI-assisted contouring is safe and beneficial to ROs working in LMICs. Prospective clinical trials on AI-assisted contouring should, however, be conducted upon clinical implementation to confirm the effects.
- 1 August 2024
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 10 (10) , e2400173
Open AccessPotential of E-Learning Interventions and Artificial Intelligence–Assisted Contouring Skills in Radiotherapy: The ELAISA Study
PURPOSE: Most research on artificial intelligence–based auto-contouring as template (AI-assisted contouring) for organs-at-risk (OARs) stem from high-income countries. The effect and safety are, however, likely to depend on local factors. This study aimed to investigate the effects of AI-assisted contouring and teaching on contouring time and contour quality among radiation oncologists (ROs) working in low- and middle-income countries (LMICs). MATERIALS AND METHODS: Ninety-seven ROs were randomly assigned to either manual or AI-assisted contouring of eight OARs for two head-and-neck cancer cases with an in-between teaching session on contouring guidelines. Thereby, the effect of teaching (yes/no) and AI-assisted contouring (yes/no) was quantified. Second, ROs completed short-term and long-term follow-up cases all using AI assistance. Contour quality was quantified with Dice Similarity Coefficient (DSC) between ROs' contours and expert consensus contours. Groups were compared using absolute differences in medians with 95% CIs. RESULTS: AI-assisted contouring without previous teaching increased absolute DSC for optic nerve (by 0.05 [0.01; 0.10]), oral cavity (0.10 [0.06; 0.13]), parotid (0.07 [0.05; 0.12]), spinal cord (0.04 [0.01; 0.06]), and mandible (0.02 [0.01; 0.03]). Contouring time decreased for brain stem (–1.41 [–2.44; –0.25]), mandible (–6.60 [–8.09; –3.35]), optic nerve (–0.19 [–0.47; –0.02]), parotid (–1.80 [–2.66; –0.32]), and thyroid (–1.03 [–2.18; –0.05]). Without AI-assisted contouring, teaching increased DSC for oral cavity (0.05 [0.01; 0.09]) and thyroid (0.04 [0.02; 0.07]), and contouring time increased for mandible (2.36 [–0.51; 5.14]), oral cavity (1.42 [–0.08; 4.14]), and thyroid (1.60 [–0.04; 2.22]). CONCLUSION: The study suggested that AI-assisted contouring is safe and beneficial to ROs working in LMICs. Prospective clinical trials on AI-assisted contouring should, however, be conducted upon clinical implementation to confirm the effects.
- Open Access
- 3 August 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 188, 109844
Stereotactic Arrhythmia Radioablation (STAR): Assessment of cardiac and respiratory heart motion in ventricular tachycardia patients - A STOPSTORM.eu consortium review
- 3 August 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 188, 109844
Open AccessStereotactic Arrhythmia Radioablation (STAR): Assessment of cardiac and respiratory heart motion in ventricular tachycardia patients - A STOPSTORM.eu consortium review
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S787-S788
OC-0940 Assessment of cardiorespiratory motion for cardiac radioablation using a digital 17-segment model
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S787-S788
OC-0940 Assessment of cardiorespiratory motion for cardiac radioablation using a digital 17-segment model
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S1701-S1702
PO-1945 Balancing Robustness and Adaptation for Proton Therapy of Lung Cancer Patients
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S1701-S1702
PO-1945 Balancing Robustness and Adaptation for Proton Therapy of Lung Cancer Patients
- Open Access
- 19 May 2023
- Published by Elsevier in Journal of the National Cancer Center
- Vol. 3 (2) , 135-140
Quality assurance and safety of hippocampal avoidance prophylactic cranial irradiation in the multicenter randomized phase III trial (NCT01780675)
- 19 May 2023
- Published by Elsevier in Journal of the National Cancer Center
- Vol. 3 (2) , 135-140
Open AccessQuality assurance and safety of hippocampal avoidance prophylactic cranial irradiation in the multicenter randomized phase III trial (NCT01780675)
- Open Access
- 1 September 2020
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 15, 29-36
The role of alexithymia and empathy on radiation therapists’ professional quality of life
- 1 September 2020
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 15, 29-36
Open AccessThe role of alexithymia and empathy on radiation therapists’ professional quality of life
- Open Access
- 1 September 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 124 (3) , 513-520
A novel concept for tumour targeting with radiation: Inverse dose-painting or targeting the “Low Drug Uptake Volume”
- 1 September 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 124 (3) , 513-520
Open AccessA novel concept for tumour targeting with radiation: Inverse dose-painting or targeting the “Low Drug Uptake Volume”